. 2022 Jul 6;9:912217. doi: 10.3389/fnut.2022.912217

TABLE 1.

Participants’ baseline characteristics.

	Placebo (n = 16)	Low-QG (n = 16)	High-QG (n = 16)	P-value
Age (y)^a	59.8 ± 6.1	60.7 ± 6.1	60.1 ± 7.8	0.930
Sex (men/women)^b	8/8	7/9	7/9	0.920
Height (cm)^a	161.8 ± 6.1	161.6 ± 10.4	159.5 ± 11.2	0.754
Weight (kg)^a	57.8 ± 8.4	58.5 ± 9.2	57.4 ± 12.9	0.952
SMI (kg/m²)^a	7.0 ± 0.9	7.0 ± 1.1	7.0 ± 1.1	0.993

Values are expressed as means ± standard deviation. There was no significant difference among the groups in baseline data (^aANOVA, ^bchi-squared test). QG, quercetin glycoside; SMI, skeletal muscle quantity index.